Fortive Corporation
—- Market cap
- $16.62B
- Debt
- —
- Cash
- −$375.50M
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 ·
Decision snapshot: FTV stock price near parity vs ABT $54.51 current versus $48.07 implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ABT's multiple
Implied fair value · at FTV's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Higher P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Fortive Corporation · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
ABBOTT LABORATORIES · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
EMERSON ELECTRIC CO
FTV vs EMR
HONEYWELL INTERNATIONAL INC
FTV vs HON
ROCKWELL AUTOMATION, INC
FTV vs ROK
Keysight Technologies, Inc.
FTV vs KEYS
TELEDYNE TECHNOLOGIES INC
FTV vs TDY
AMETEK INC/
FTV vs AME
Johnson & Johnson
FTV vs JNJ
Medtronic plc
FTV vs MDT
BECTON DICKINSON & CO
FTV vs BDX
Thermo Fisher Scientific Inc.
FTV vs TMO
DANAHER CORP /DE/
FTV vs DHR
BOSTON SCIENTIFIC CORP
FTV vs BSX
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe FTV can reaccelerate growth and sustain margins despite its 3.9x net debt/EBITDA, then holding or adding may be justified; otherwise, the data argue for caution because FTV trades at a richer P/E than ABT while delivering weaker growth, lower ROIC, and higher leverage.
FTV's current price of $59.21 sits above the provided implied P/E value of $49.16, indicating about 17.0% downside versus this ABT-based framework. The gap is driven mainly by FTV's richer earnings and EBITDA multiples versus ABT, while its sales multiple is only slightly above ABT's.
Supporting Metrics